TRAVERE THERAPEUTICS INC

Ticker: TVTX CUSIP: 89422G107 Class: Common Stock

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 623,390 Value ($000) $23,820 Avg Close $32.52 Range $23.22 - $42.13
Q3 2025
Shares 857,899 Value ($000) $20,504 Avg Close $18.80 Range $14.36 - $28.69
Q2 2025
Shares 685,511 Value ($000) $10,146 Avg Close $16.57 Range $12.91 - $22.07
Q1 2025
Shares 495,177 Value ($000) $8,874 Avg Close $20.30 Range $16.80 - $25.29
Q4 2024
Shares 426,726 Value ($000) $7,434 Avg Close $17.69 Range $13.24 - $20.33
Q3 2024
Shares 525,381 Value ($000) $7,350 Avg Close $10.42 Range $7.72 - $15.36
Q2 2024
Shares 472,396 Value ($000) $3,883 Avg Close $6.73 Range $5.12 - $8.38
Q1 2024
Shares 416,653 Value ($000) $3,212 Avg Close $8.44 Range $7.11 - $10.27
Q4 2023
Shares 287,811 Value ($000) $2,587 Avg Close $7.28 Range $5.25 - $9.70
Q3 2023
Shares 290,833 Value ($000) $2,600 Avg Close $14.11 Range $7.00 - $17.57
Q2 2023
Shares 290,911 Value ($000) $4,468 Avg Close $18.19 Range $14.51 - $23.18
Q1 2023
Shares 277,012 Value ($000) $6,230 Avg Close $21.26 Range $17.82 - $23.18
Q4 2022
Shares 244,812 Value ($000) $5,148 Avg Close $21.19 Range $17.97 - $26.55
Q3 2022
Shares 246,849 Value ($000) $6,082 Avg Close $25.84 Range $22.00 - $29.14
Q2 2022
Shares 237,551 Value ($000) $5,756 Avg Close $25.15 Range $20.80 - $30.35
Q1 2022
Shares 235,774 Value ($000) $6,076 Avg Close $26.55 Range $22.16 - $31.50
Q4 2021
Shares 230,369 Value ($000) $7,151 Avg Close $28.16 Range $23.73 - $31.65
Q3 2021
Shares 168,250 Value ($000) $4,080 Avg Close $18.37 Range $12.75 - $25.78
Q4 2020
Shares 12,388 Value ($000) $338 Avg Close $23.35 Range $18.32 - $28.19